The Canmat Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Medical Conditions: Diagnostic,Assessment,and Treatment Principles
Restricted accessReview articleFirst published online February, 2012
The Canmat Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Medical Conditions: Diagnostic,Assessment,and Treatment Principles
: Medical comorbidity is commonly encountered in individuals with major depressive disorder (MDD) and bipolar disorder (BD). The presence of medical comorbidity has diagnostic, prognostic, treatment, and etiologic implications underscoring the importance of timely detection and treatment.
Methods
: A selective review of relevant articles and reviews published in English-language databases (1968 to April 2011) was conducted. Studies describing epidemiology, temporality of onset, treatment implications, and prognosis were selected for review.
Results
A growing body of evidence from epidemiologic, clinical, and biologic studies suggests that the relationship between medical illness and mood disorder is bidirectional in nature. It provides support for the multiplay of shared and specific etiologic factors interlinking these conditions.
Conclusion
This article describes the complex interactions between medical illness and mood disorders and provides a meaningful approach to their comorbid clinical diagnosis and management.
EvansDL, CharneyDS, LewisL, . Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58:175–189.
2.
KatonWJ.Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–226.
3.
Van der KooyK, van HoutH, MarwijkH, . Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry. 2007;22:613–626.
4.
RamasubbuR, PattenSB.Effect of depression on stroke morbidity and mortality. Can J Psychiatry. 2003;48:250–257.
5.
HesdorfferDC, HauserWA, AnnegersJF, . Major depression is a risk factor for seizures in older adults. Ann Neurol. 2000;47:246–249.
6.
GreenRC, CupplesLA, KurzA, . Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol. 2003;60:753–759.
7.
NouwenA, LloydCE, PouwerF.Depression and type 2 diabetes over the lifespan: a meta-analysis. Response to Mezuk. Diabetes Care. 2009;32: e56–e57.
8.
PenninxBW, GuralnikJM, PahorM, . Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst. 1998;90:1888–1893.
9.
LillbergK, VerkasaloPK, KaprioJ, . Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol. 2003;157:415–423.
10.
PerrettaP, AkiskalHS, NisitaC, . The high prevalence of bipolar II and associated cyclothymic and hyperthymic temperaments in HIV-patients. J Affect Disord. 1998;50:215–224.
11.
Frasure-SmithN, LespéranceF.Recent evidence linking coronary heart disease and depression. Can J Psychiatry. 2006;51:730–737.
12.
AlmeidaOP, XiaoJ.Mortality associated with incident mental health disorders after stroke. Aust N Z J Psychiatry. 2007;41:274–281.
13.
ParikhRM, RobinsonRG, LipseyJR, . The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol. 1990;47:785–789.
14.
KannerAM.Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54:388–398.
15.
De GrootM, AndersonR, FreedlandKE, . Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619–630.
16.
StommelM, GivenBA, GivenCW.Depression and functional status as predictors of death among cancer patients. Cancer. 2002;94:2719–2727.
17.
LesermanJ.HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54:295–306.
18.
WulsinLR, VaillantGE, WellsVE.A systematic review of the mortality of depression. Psychosom Med. 1999;61:6–17.
19.
SteinMB, CoxBJ, AfifiTO, . Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med. 2006;36:587–596.
20.
MoussaviS, ChatterjiS, VerdesE, . Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–858.
21.
IosifescuDV, NierenbergAA, AlpertJE, . Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics. 2004;45:419–425.
22.
DaneseA, MoffittTE, HarringtonH, . Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med. 2009;163:1135–1143.
23.
NomuraY, Brooks-GunnJ, DaveyC, . The role of perinatal problems in risk of co-morbid psychiatric and medical disorders in adulthood. Psychol Med. 2007;37:1323–1334.
24.
HermesGL, DelgadoB, TretiakovaM, . Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc Natl Acad Sci U S A. 2009;106:22393–22398.
25.
LokeYK, TrivediAN, SinghS.Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2008;27:31–40.
26.
RichardsJB, PapaioannouA, AdachiJD, . Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167:188–194.
27.
RooseSP.Treatment of depression in patients with heart disease. Biol Psychiatry. 2003;54:262–268.
28.
NgF, MammenOK, WiltingI, . The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;11:559–595.
29.
KatonW, SullivanMD.Depression and chronic medical illness. J Clin Psychiatry. 1990;51:3–11.
30.
NewportDJ, NemeroffCB.Assessment and treatment of depression in the cancer patient. J Psychosom Res. 1998;45:215–237.
AndreasenNC, WinokurG.Secondary depression: familial, clinical, and research perspectives. Am J Psychiatry. 1979;136:62–66.
33.
AkiskalHS, RosenthalRH, RosenthalTL, . Differentiation of primary affective illness from situational, symptomatic, and secondary depressions. Arch Gen Psychiatry. 1979;36:635–643.
34.
HirschfeldRM, KlermanGL, AndreasenNC, . Situational major depressive disorder. Arch Gen Psychiatry. 1985;42:1109–1114.
35.
KendlerKS, GardnerCO, PrescottCA.Toward a comprehensive developmental model for major depression in men. Am J Psychiatry. 2006;163:115–124.
36.
KohenR, CainKC, MitchellPH, . Association of serotonin transporter gene polymorphisms with poststroke depression. Arch Gen Psychiatry. 2008;65:1296–1302.
37.
TenevVT, RobinsonRG, JorgeRE.Is family history of depression a risk factor for poststroke depression? Meta-analysis. Am J Geriatr Psychiatry. 2009;17:276–280.
38.
RaisonCL, MillerAH.Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry. 2003;54:283–294.
39.
Cohen-ColeSA, BrownFW, McDanielJS.Diagnostic assessment of depression in the medically ill. In: StoudemireA, FogelB, eds. Psychiatric care of the medical patient.New York, NY: Oxford University Press; 1993:53–70.
40.
RobinsonRG.Phenomenology and specificity of depressive symptoms. The clinical neuropsychiatry of stroke: cognitive, behavioral, and emotional disorders following vascular brain injury. New York, NY: Cambridge University Press; 1998:60–73.
41.
GoldmanMB.Neuropsychiatric features of endocrine disorders. In: YudofskySC, HaleRE, eds. The American Psychiatric Press textbook of the neuropsychiatry.Washington DC: American Psychiatric Press; 1998:519–540.
42.
GainottiG, AntonucciG, MarraC, . Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry. 2001;71:258–261.
43.
HallRC, BeresfordTP, BlowFC.Depression and medical illness: an overview in presentations of depression: Depressive symptoms. In: CameronOG, ed. New York, NY: Wiley Press; 1987:401–414.
44.
IosifescuDV.Treating depression in the medically ill. Psychiatr Clin North Am. 2007;30:77–90.
45.
LamRW, MichalakEE, SwinsonRP.Assessment scales in depression and anxiety. London, United Kingdom: Taylor and Francis; 2005.
46.
ParkerG, HiltonT, BainsJ, . Cognitive-based measures screening for depression in the medically ill: the DMI-10 and the DMI-18. Acta Psychiatr Scand. 2002;105:419–426.
47.
SpitzerRL, KroenkeK, WilliamsJB.Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282:1737–1744.
48.
WilliamsLS, BrizendineEJ, PlueL, . Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke. 2005;36:635–638.
49.
ChochinovHM, WilsonKG, EnnsM, . “Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry. 1997;154:674–676.
50.
WatkinsC, DanielsL, JackC, . Accuracy of a single question in screening for depression in a cohort of patients after stroke: comparative study. BMJ. 2001;323:1159.
51.
BergA, LönnqvistJ, PalomäkiH, . Assessment of depression after stroke: a comparison of different screening instruments. Stroke. 2009;40:523–529.
52.
DeVaneCL, MarkowitzJS.Avoiding psychotropic drug interactions in the cardiovascular patient. Bull Menninger Clin. 2000;64:49–59.
53.
WeissJ, DormannSM, Martin-FacklamM, . Inhibition of P-glycoprotein by newer antidepressants. J Pharmacol Exp Ther. 2003;305:197–204.
54.
EttingerAB, KustraRP, HammerAE.Effect of lamotrigine on depressive symptoms in adult patients with epilepsy. Epilepsy Behav. 2007;10:148–154.
55.
LamplC, HuberG, AdlJ, . Two different doses of amitriptyline ER in the prophylaxis of migraine: long-term results and predictive factors. Eur J Neurol. 2009;16:943–948.
56.
GlassmanAH, RooseSP, BiggerJTJr.The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA. 1993;269:2673–2675.
57.
BerkmanLF, BlumenthalJ, BurgM, . Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106–3116.
58.
LincolnNB, FlannaghanT.Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke. 2003;34:111–115.
59.
Mynors-WallisLM, GathDH, Lloyd-ThomasAR, . Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310:441–445.
